42 results
Page 2 of 3
20-F/A
o3qjgc36so6a
23 Mar 15
Annual report (foreign) (amended)
12:00am
6-K
EX-99
5y0jvwkuh6j31du
2 Mar 15
Current report (foreign)
12:00am
6-K
EX-99
803jje2 05odsh
24 Sep 13
BioLineRx Announces Regulatory Submission for Phase
12:00am
424B3
hqrf8k9k3 4z9tqx
8 Aug 13
Prospectus supplement
12:00am
6-K
EX-99
ls1 rq3m4lg2p82zf
6 Aug 13
BioLineRx Reports Second Quarter 2013 Results
12:00am
6-K
EX-99
7p1lyn0 q82armcczt
29 Jul 13
BioLineRx Announces CE-Mark Registration
12:00am
424B5
0m9yhm7t1
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
uevx pk2ke5
15 Oct 12
Prospectus supplement
12:00am
F-1
xkozmvyn8oun1ggtr0u
2 Oct 12
Registration statement (foreign)
12:00am
424B3
ba8n84nzd1qjp
28 Mar 12
Prospectus supplement
12:00am
20-F
rne8p
22 Mar 12
Annual report (foreign)
12:00am
6-K
EX-99
i2vmx i1vtgr
28 Nov 11
BioLineRx Reports Third Quarter 2011 Financial Results
12:00am
6-K
EX-1
kvo5dj7y
21 Nov 11
BioLineRx Announces Receipt of Approval in India
12:00am
20FR12B/A
rzh13pa50qi3m
15 Jul 11
Initial registration of securities (foreign private issuers) (amended)
12:00am
20FR12B
7ng rqrcqloh
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am
20FR12B
EX-4.17
szzdc4k5mt
1 Jul 11
Initial registration of securities (foreign private issuers)
12:00am